News J&J asks FDA for emergency clearance for single-shot COVID-1... Johnson & Johnson’s Janssen unit has filed its single dose COVID-19 vaccine candidate with the FDA, asking for an Emergency Use Authorization (EUA).
R&D J&J and medical device innovation: the pharmaphorum podcast In episode 27 of the pharmaphorum podcast I’m joined by Erin McEachren, who’s EU regional vice president at J&J Surgical Vision.
Views & Analysis The top 5 pharma M&A deals of 2020 2020’s M&A activity hasn’t quite reached the heights of last year’s, where two pharma mega-mergers –
News Janssen combines Darzalex with COVID-19 drug in new multiple... Janssen has submitted a new combination regimen for its blockbuster multiple myeloma drug Darzalex for approval with the FDA and EMA, hoping to give the treatment another edge over emerging comp
News Canada signs deals for J&J, Novavax COVID vaccines The Canadian government has reached agreements in principle with J&J and Novavax to buy their coronavirus vaccine candidates.
Views & Analysis Rebooting the healthcare system post-COVID-19 Janssen’s Iris Zemzoum looks at seven ways the healthcare and pharma sectors need to change in the wake of COVID-19.
R&D Modelling biologics: Challenges and opportunities, with Dr D... From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.